Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $359.59 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $109.21 | 5 | $0 (2024) |
| Alkermes, Inc. | $36.46 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $28.64 | 1 | $0 (2021) |
| Celgene Corporation | $25.83 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $23.74 | 1 | $0 (2021) |
| MAYNE PHARMA INC. | $23.04 | 1 | $0 (2022) |
| IBSA Pharma Inc. | $22.94 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.18 | 1 | $0 (2021) |
| Genentech USA, Inc. | $19.34 | 1 | $0 (2021) |
| GENZYME CORPORATION | $18.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.33 | 5 | ABBVIE INC. ($88.50) |
| 2023 | $19.82 | 1 | Alkermes, Inc. ($19.82) |
| 2022 | $45.98 | 2 | MAYNE PHARMA INC. ($23.04) |
| 2021 | $179.46 | 9 | Esperion Therapeutics, Inc. ($28.64) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.10 | General |
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Neuroscience | ||||||
| 06/09/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CNS | ||||||
| 08/26/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $23.04 | General |
| 04/01/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Endocrinology | ||||||
| 12/28/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 07/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: CNS | ||||||
| 04/17/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 02/26/2021 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: HIV | ||||||
| 02/05/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/29/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Virology & Specialty Care | ||||||
| 01/08/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 200 | 278 | $32,905 | $15,390 |
| 2022 | 4 | 151 | 202 | $26,185 | $13,760 |
| 2021 | 5 | 145 | 167 | $19,193 | $10,161 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 208 | $27,060 | $12,216 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $3,000 | $1,735 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,100 | $1,092 | 52.0% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 23 | 28 | $700.00 | $302.40 | 43.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 15 | $45.00 | $44.10 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 120 | $15,600 | $8,059 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 38 | $6,685 | $3,372 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,200 | $2,012 | 62.9% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 20 | 28 | $700.00 | $316.65 | 45.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 70 | $9,120 | $4,742 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $4,000 | $2,570 | 64.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 30 | $5,250 | $2,451 | 46.7% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2021 | 26 | 31 | $775.00 | $350.35 | 45.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 16 | $48.00 | $48.00 | 100.0% |
About Terese Sybor
Terese Sybor is a Family healthcare provider based in Clarksville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1225548308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Terese Sybor has received a total of $359.59 in payments from pharmaceutical and medical device companies, with $114.33 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($359.59).
As a Medicare-enrolled provider, Sybor has provided services to 496 Medicare beneficiaries, totaling 647 services with total Medicare billing of $39,310. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clarksville, MD
- Active Since 10/03/2017
- Last Updated 03/12/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225548308
Products in Payments
- BOTOX (Biological) $47.68
- UBRELVY (Drug) $39.43
- NEXLETOL (Drug) $28.64
- ZEPOSIA (Drug) $25.83
- AJOVY (Biological) $23.74
- Tirosint (Drug) $22.94
- TRINTELLIX (Drug) $20.18
- Vivitrol (Drug) $19.82
- Xofluza (Drug) $19.34
- DUPIXENT (Biological) $18.50
- Descovy (Drug) $17.41
- VIVITROL (Drug) $16.64
- ADHANSIA XR (Drug) $14.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clarksville
Rhonda Hettinger, Np, NP
Family — Payments: $35,080
Kayla Teives, Np-C, NP-C
Family — Payments: $8,369
Danielle Conroy, Np, NP
Family — Payments: $5,696
Mrs. Terry Holt, Fnp, FNP
Family — Payments: $4,648
Mrs. Carrie Hinton, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,601
Charlsie Deloach, Fnp-Cb, FNP-CB
Family — Payments: $4,589